Ira Fedder is listed as a director on 7 SEC Form D filings by 1 issuer between Apr 2016 and Nov 2023: Quadrant Biosciences Inc (Syracuse, NY — biotechnology — 2016–2023; $3.6M reported sold to 36 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andrew Rock (7 shared filings), Richard Bongo (7 shared filings), Richard Uhlig (7 shared filings), Bryan Greene (4 shared filings), James Croke (4 shared filings) and 18 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ira. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 4 court cases matching the name, 7 bankruptcy cases matching the name listed in Key records below.
What this means 11 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for Ira Fedder and found 8 differences, 1 worth asking the sponsor about: 31% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.